NEFL and neurodegenerative disease: NfL, however, is a very promising candidate, with evidence in the literature supporting the value of sNfL as a sensitive and clinically meaningful blood biomarker to monitor neuronal tissue damage and the effects of therapies on neurodegenerative disease (26–30).